Zoetis | ZTS - Current Assets

Stock Price
122.91
Daily Change
-2.03 -1.62%
Monthly
-4.99%
Yearly
-28.64%
Q1 Forecast
120.98

Zoetis reported $6.58B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
Align Technology USD 2.53B 86.04M Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Charles River Laboratories USD 1.53B 62.24M Sep/2025
Dentsply International USD 2.07B 106M Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Henry Schein USD 4.4B 152M Sep/2025
Idexx Laboratories USD 1.48B 114.7M Sep/2025
Illumina USD 2.8B 155M Sep/2025
IQVIA Holdings USD 5.98B 366M Sep/2025
J&J USD 54.61B 113M Sep/2025
Laboratory Of America USD 4.08B 8.4M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Neogen USD 574.58M 50.52M Sep/2025
Pacira USD 562.75M 182.86M Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Quest Diagnostics USD 2.41B 209M Sep/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Sanofi EUR 30.95B 8.99B Dec/2025
Zoetis USD 6.58B 660M Sep/2025